The data streaming platform's shares soared 29% following the announcement of the deal.
BridgeBio Pharma (BBIO) has surged 145% over the past year, reaching an all-time high of $75.10. BBIO maintains a strong technical profile with a 100% “Buy” Barchart opinion. Revenue is projected to...
The company targets to build 15 gigawatts of power capacity for data centers by 2035.
Veralto Corporation stock has lagged behind the S&P 500 over the past year, while analysts remain moderately bullish about its prospects.
In a new blog post, Michael Burry has compared Palantir to DiamondCluster.
Netcapital stock doubles as the company announces a blockchain pivot and names Rich Wheeless its new chief executive. Here’s why NCPL shares still aren’t worth owning heading into 2026.
Galaxy Digital shares soared on Tuesday amid a broader crypto market recovery. A Citizens’ analyst says GLXY shares could roughly double from here in 2026.
Livestock futures are welcoming the speculators to the buy sides. Here’s what to watch now.
March Canadian dollar futures present a buying opportunity on more price strength.
The real estate investment trust owner of casinos and other hospitality real estate hit its 11th new 52-week low of the past 12 months. Here’s why Income investors should consider laying down a bet.
